CDRE (NYSE: CDRE) insider plans Rule 144 sale of 20,435 common shares
Rhea-AI Filing Summary
An affiliate of CDRE has filed a Form 144 notice to sell up to 20,435 shares of common stock through UBS Financial Services Inc.. The planned sale, listed for execution on or about 12/12/2025 on the NYSE, has an indicated aggregate market value of $899,140. The shares were originally acquired as restricted stock units (RSUs) from the issuer on 03/18/2022. The filing also notes that there were 40,663,844 shares of this class outstanding at the time referenced, providing context for the size of the proposed transaction.
Positive
- None.
Negative
- None.
FAQ
How many CDRE shares are planned to be sold under this Form 144?
The notice covers a proposed sale of 20,435 shares of CDRE common stock.
What is the aggregate market value of the CDRE shares in this Rule 144 sale?
The proposed sale has an indicated aggregate market value of $899,140.
On which exchange are the CDRE shares expected to be sold?
The shares are expected to be sold on the NYSE, as stated in the filing.
When were the CDRE shares to be sold originally acquired?
The 20,435 shares were acquired on 03/18/2022 as RSUs from the issuer.
How many CDRE common shares were outstanding for context?
There were 40,663,844 shares of CDRE common stock outstanding at the time referenced in the notice.
Which broker is handling the planned CDRE Form 144 sale?
The filing lists UBS Financial Services Inc. as the broker for the proposed sale.